The deal totalled somewhere in the range of $2bn to $2.5bn, making it one of the largest deals of the year.
3 min read · 21 July 2022
The Nuveen subsidiary is building a team to target GP-led deals in the US mid-market, a year after executing its own large secondaries deal.
2 min read · 19 July 2022
The firm targets growth assets via GP-led deals, highly concentrated LP stake trades and preferred equity.
2 min read · 19 July 2022
The asset manager, which has $170bn in alternatives AUM, is revisiting the strategy having last raised a dedicated secondaries fund in 2016.
2 min read · 14 July 2022
The sale, valued at around $6bn by net asset value plus unfunded commitments, ranks among the largest to ever trade.
3 min read · 14 July 2022
Impacts from the broader economy, such as inflation, geopolitical turmoil and slower growth, have made it tougher to value assets in secondaries processes, with a wide gap between buyer and seller expectations.
3 min read · 14 July 2022
The adviser and placement agent sees a growing opportunity in the US lower middle market, particularly in preferred equity.
2 min read · 07 July 2022
Of the sellers, 12% said they had tapped the secondaries market to offload private credit fund interests more than once.
2 min read · 04 July 2022
Secondaries-focused PA Capital joined forces with New York Life’s private equity affiliate GoldPoint Partners and lender Madison Capital Funding, rebranding as Apogem Capital in April.
2 min read · 30 June 2022
Some large processes are hitting delays as pricing is shifting in the changing markets, and building large enough syndicates for mega-deals has become challenging.
3 min read · 30 June 2022
